Literature DB >> 19765108

Hepatic extracellular matrix alterations in dogs naturally infected with Leishmania (Leishmania) chagasi.

Ferdinan Almeida Melo1, Eliane Perlatto Moura, Raul Rio Ribeiro, Cíntia Fontes Alves, Marcelo Vidigal Caliari, Washington Luiz Tafuri, Kátia da Silva Calabrese, Wagner Luiz Tafuri.   

Abstract

Summary The aim of this work was to study alterations in the extracellular matrix of liver in dogs naturally infected with Leishmania (Leishmania) chagasi that are correlated with clinical aspects and with histological, parasitological and immunological findings. The study was carried out on 30 dogs, 10 uninfected (control group) and 20 infected. The infected animals were further divided into two groups: an asymptomatic group of 10 dogs without clinical signs of the disease; and a symptomatic group of 10 dogs with classical clinical signs. All thirty animals were mongrel dogs of undefined age, obtained from the municipality of Belo Horizonte, MG, metropolitan area. During necropsy, liver fragments were collected and fixed in 10% buffered formaldehyde for histological examination. Paraffined sections of the tissues were stained with haematoxylin-eosin, Gomori's ammoniacal silver stain for reticular fibres and strepto-avidin peroxidase for immunohistochemical detection of Leishmania amastigotes. Frozen tissue sections were stained by immunofluorescence for fibronectin (FN) and laminin (LN). Liver collagen deposition was significantly greater in the infected than the control animals and differed significantly between the symptomatic and asymptomatic dogs. There was a positive correlation between the parasite load and liver collagen deposition. The increased collagen deposition in infected animal livers may be associated with the parasite burden. Adhesive FN and LN fibres were significantly more highly expressed in the livers of symptomatic than of asymptomatic dogs. Our results demonstrate that canine visceral leishmaniasis causes fibrogenesis in liver, associated with the parasite load and degenerative processes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19765108      PMCID: PMC2768152          DOI: 10.1111/j.1365-2613.2009.00681.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  64 in total

Review 1.  Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury.

Authors:  S L Friedman
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

Review 2.  Fibrogenesis I. New insights into hepatic stellate cell activation: the simple becomes complex.

Authors:  F J Eng; S L Friedman
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-07       Impact factor: 4.052

3.  Canine visceral leishmaniosis: a remarkable histopathological picture of one case reported from Brazil.

Authors:  W L Tafuri; M R de Oliveira; M N Melo; W L Tafuri
Journal:  Vet Parasitol       Date:  2001-04-02       Impact factor: 2.738

4.  The clinico-haematological features and pathology of leishmaniasis in a dog in Nigeria.

Authors:  V O Anosa; A L Idowu
Journal:  Zentralbl Veterinarmed B       Date:  1983-09

5.  Endemic canine leishmaniasis.

Authors:  D C Anderson; R G Buckner; B L Glenn; D W MacVean
Journal:  Vet Pathol       Date:  1980-01       Impact factor: 2.221

6.  Tissue cytokine responses in canine visceral leishmaniasis.

Authors:  R J Quinnell; O Courtenay; M A Shaw; M J Day; L M Garcez; C Dye; P M Kaye
Journal:  J Infect Dis       Date:  2001-03-21       Impact factor: 5.226

Review 7.  The leishmaniases as emerging and reemerging zoonoses.

Authors:  R W Ashford
Journal:  Int J Parasitol       Date:  2000-11       Impact factor: 3.981

8.  An alternative immunohistochemical method for detecting Leishmania amastigotes in paraffin-embedded canine tissues.

Authors:  Wagner Luiz Tafuri; Renato de Lima Santos; Rosa Maria Esteves Arantes; Ricardo Gonçalves; Maria Norma de Melo; Marilene Suzan Marques Michalick; Washington Luiz Tafuri
Journal:  J Immunol Methods       Date:  2004-09       Impact factor: 2.303

9.  Visceral leishmaniasis in a dog: clinical, hematological and pathological observations.

Authors:  L Tryphonas; Z Zawidzka; M A Bernard; E A Janzen
Journal:  Can J Comp Med       Date:  1977-01

10.  Cervical, mandibular, and parotid lymph nodes of dogs naturally infected with Leishmania infantum: a histopathologic and immunohistochemistry study and its correlation with facial skin lesions.

Authors:  M M S Costa; W G Lima; M M Figueiredo; M S M Michalick; W L Tafuri; W L Tafuri
Journal:  Vet Pathol       Date:  2008-09       Impact factor: 2.221

View more
  13 in total

1.  Immunohistochemical study of hepatic fibropoiesis associated with canine visceral leishmaniasis.

Authors:  Igor M V M Madeira; Debora M O Pereira; Aline A Sousa; Cesar A Vilela; Izabela F G Amorim; Marcelo V Caliari; Carolina C Souza; Wagner L Tafuri
Journal:  Int J Exp Pathol       Date:  2016-05-31       Impact factor: 1.925

2.  Immunohistochemical study of renal fibropoiesis associated with dogs naturally and experimentally infected with two different strains of Leishmania (L.) infantum.

Authors:  Adriano F Alves; Ramon A Pereira; Helida M de Andrade; David M Mosser; Wagner L Tafuri
Journal:  Int J Exp Pathol       Date:  2019-11-06       Impact factor: 1.925

3.  Canine visceral leishmaniasis as a systemic fibrotic disease.

Authors:  Lucelia C Silva; Rodrigo S Castro; Maria M Figueiredo; Marilene S M Michalick; Washington L Tafuri; Wagner L Tafuri
Journal:  Int J Exp Pathol       Date:  2013-02-19       Impact factor: 1.925

4.  Immunodetection of hepatic stellate cells in dogs with visceral leishmaniasis.

Authors:  Natália Cassaro Marques; Pamela Rodrigues Reina Mo Reira; Paulo Henrique Leal Bertolo; Fábio Nelson Gava; Rosemeri de Oliveira Vasconcelos
Journal:  Parasitol Res       Date:  2018-04-27       Impact factor: 2.289

5.  Toll receptors type-2 and CR3 expression of canine monocytes and its correlation with immunohistochemistry and xenodiagnosis in visceral leishmaniasis.

Authors:  Izabela Ferreira Gontijo de Amorim; Sydnei Magno da Silva; Maria Marta Figueiredo; Eliane Perlatto Moura; Rodrigo Soares de Castro; Tatjana Keesen de Souza Lima; Nelder de Figueiredo Gontijo; Marilene Suzan Marques Michalick; Kenneth John Gollob; Wagner Luiz Tafuri
Journal:  PLoS One       Date:  2011-11-30       Impact factor: 3.240

6.  Leishmania amazonensis promastigotes in 3D Collagen I culture: an in vitro physiological environment for the study of extracellular matrix and host cell interactions.

Authors:  Debora B Petropolis; Juliany C F Rodrigues; Nathan B Viana; Bruno Pontes; Camila F A Pereira; Fernando C Silva-Filho
Journal:  PeerJ       Date:  2014-04-03       Impact factor: 2.984

7.  A potential link among antioxidant enzymes, histopathology and trace elements in canine visceral leishmaniasis.

Authors:  Carolina C Souza; Tatiane de O Barreto; Sydnei M da Silva; Aldair W J Pinto; Maria M Figueiredo; Olguita G Ferreira Rocha; Silvia D Cangussú; Wagner L Tafuri
Journal:  Int J Exp Pathol       Date:  2014-04-26       Impact factor: 1.925

8.  Morphophysiological changes in the splenic extracellular matrix of Leishmania infantum-naturally infected dogs is associated with alterations in lymphoid niches and the CD4+ T cell frequency in spleens.

Authors:  Aurea Virginia Andrade da Silva; Fabiano Borges Figueiredo; Rodrigo Caldas Menezes; Arthur Augusto Mendes-Junior; Luisa Helena Monteiro de Miranda; Elisa Cupolillo; Renato Porrozzi; Fernanda Nazaré Morgado
Journal:  PLoS Negl Trop Dis       Date:  2018-04-20

Review 9.  The Contribution of Immune Evasive Mechanisms to Parasite Persistence in Visceral Leishmaniasis.

Authors:  Elisangela Oliveira de Freitas; Fabiana Maria de Souza Leoratti; Célio Geraldo Freire-de-Lima; Alexandre Morrot; Daniel Ferreira Feijó
Journal:  Front Immunol       Date:  2016-04-22       Impact factor: 7.561

10.  Insights on adaptive and innate immunity in canine leishmaniosis.

Authors:  Shazia Hosein; Damer P Blake; Laia Solano-Gallego
Journal:  Parasitology       Date:  2016-04-20       Impact factor: 3.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.